Home Clinical Examination The Gastrointestinal System

The Gastrointestinal System

πŸ“‹ Key Information Summary

πŸ“‹
  • A thorough gastrointestinal (GI) history is the cornerstone of diagnosis; always cover the presenting complaint using SOCRATES (Site, Onset, Character, Radiation, Associated symptoms, Timing, Exacerbating/relieving factors, Severity) for abdominal pain.
  • Dysphagia requires urgent investigation to exclude oesophageal malignancy β€” differentiate oropharyngeal (transfer) from oesophageal (transport) dysphagia and solids vs. liquids progression.
  • Altered bowel habit β€” document stool frequency, consistency (Bristol Stool Chart), presence of blood or mucus, and any tenesmus; red-flag features (weight loss, rectal bleeding, family history of colorectal cancer) mandate colonoscopy.
  • Rectal bleeding: bright red blood per rectum (PR) suggests distal colonic or anorectal source; melaena (black tarry stools) indicates upper GI bleeding proximal to the ligament of Treitz.
  • Abdominal pain patterns follow characteristic localisation β€” epigastric (peptic ulcer, pancreatitis), right upper quadrant (RUQ) (biliary colic, cholecystitis), central colicky (bowel obstruction), right iliac fossa (RIF) (appendicitis), and generalised peritonitis (rigid, silent abdomen).
  • The systematic abdominal examination follows Inspection β†’ Auscultation β†’ Percussion β†’ Palpation (IAPP) to avoid altering bowel sounds before listening.
  • Palpate the liver starting from the right iliac fossa, moving cephalad; a palpable, tender, smooth liver suggests hepatitis or congestion; an irregular, hard, non-tender liver suggests malignancy.
  • Splenomegaly is best detected with the patient supine and breathing through the mouth; percussion (Traube's space) precedes palpation from the right iliac fossa toward the left costal margin.
  • Peripheral stigmata of chronic liver disease include spider naevi (β‰₯5 is significant), palmar erythema, gynaecomastia, caput medusae, jaundice, leukonychia, clubbing, and hepatomegaly.
  • Ascites is detected by shifting dullness on percussion; always consider diagnostic paracentesis (serum-ascites albumin gradient β‰₯11 g/L indicates portal hypertension).
  • Alcohol history must be quantified in Australian standard drinks per day/week (1 standard drink β‰ˆ 10 g ethanol); CAGE questionnaire and AUDIT-C screening are essential adjuncts.
  • Weight loss of >5% over 6 months without explanation warrants investigation for GI malignancy, coeliac disease, inflammatory bowel disease (IBD), or malabsorption.
  • Aboriginal and Torres Strait Islander peoples experience disproportionately higher rates of H. pylori infection, hepatocellular carcinoma, gallstone disease, and chronic liver disease β€” always enquire sensitively about cultural factors and alcohol use.

Introduction & Australian Epidemiology

The gastrointestinal (GI) system extends from the oral cavity to the anus and includes the accessory organs β€” liver, gallbladder, and pancreas. A systematic approach to GI history-taking and clinical examination is essential for accurate diagnosis and timely referral in Australian primary and secondary care settings. GI diseases account for a substantial burden of morbidity and mortality across all Australian populations.

In Australia, colorectal cancer is the second most common cancer by incidence and the second leading cause of cancer-related mortality, with approximately 15,500 new diagnoses annually (Australian Institute of Health and Welfare, 2023). Gastro-oesophageal reflux disease (GORD) affects an estimated 10–15% of Australian adults. Inflammatory bowel disease (IBD) prevalence exceeds 100,000 Australians, with Crohn's disease and ulcerative colitis both rising in incidence. Chronic liver disease, predominantly alcohol-related liver disease and non-alcoholic fatty liver disease (NAFLD), is the eleventh leading cause of death in Australia.

⚠️
Red-flag features requiring urgent investigation or referral include: unexplained weight loss >5%, dysphagia, iron-deficiency anaemia, rectal bleeding, new change in bowel habit aged >40 years, and abdominal mass. These should prompt expedited endoscopy or CT imaging.

Aboriginal and Torres Strait Islander Australians are disproportionately affected by GI disease. Rates of hepatocellular carcinoma are approximately 2–4 times higher than in the non-Indigenous population, driven by higher prevalence of hepatitis B infection, hepatitis C, and harmful alcohol use. Gastric cancer and gallstone-related disease are also more prevalent. Culturally safe, trauma-informed history-taking and examination are critical.

This article provides a structured approach to the GI clinical encounter β€” from focused history through to systematic examination and recognition of peripheral stigmata β€” aligned with Australian medical curricula, the RACGP Clinical Competency Standards, and evidence-based practice.

GI History

The GI history should be comprehensive and structured. Begin with the presenting complaint and use the SOCRATES framework for pain. Always screen for alarm (red-flag) symptoms. The following domains must be explored in every GI consultation.

Abdominal Pain

Abdominal pain is the most common GI presenting complaint. Characterise using SOCRATES:

SOCRATES Element Key Questions Clinical Significance
Site Where exactly? Can you point with one finger? Localises to organ (see pain patterns below)
Onset Sudden vs. gradual? What were you doing? Sudden onset = perforation, rupture, mesenteric ischaemia
Character Colicky, burning, tearing, dull ache, sharp? Colicky = hollow viscus obstruction; burning = acid-related
Radiation Does it move anywhere? Shoulder tip, back, groin? Shoulder tip = diaphragmatic irritation (subphrenic, ectopic); back = pancreatitis, aortic dissection
Associated symptoms Nausea, vomiting, fever, anorexia, bowel change, urinary symptoms? Differentiates surgical vs. medical causes
Timing Constant vs. intermittent? Duration? Timing of episodes? Post-prandial (biliary, mesenteric ischaemia); nocturnal (peptic ulcer)
Exacerbating / Relieving Better or worse with food? Movement? Antacids? Relieved by food (duodenal ulcer); worsened by food (gastric ulcer, mesenteric ischaemia)
Severity Scale 0–10? Impact on function? 10/10 pain in a quiet patient = peritonitis

Dysphagia

Dysphagia (difficulty swallowing) is a red-flag symptom that mandates urgent investigation. Always differentiate:

  • Oropharyngeal (transfer) dysphagia β€” difficulty initiating swallow; nasal regurgitation; aspiration; suggests neurological cause (stroke, motor neurone disease, Parkinson's disease, myasthenia gravis).
  • Oesophageal (transport) dysphagia β€” food "sticking" retrosternally after initiating swallow. Progression from solids β†’ liquids suggests mechanical obstruction (stricture, malignancy, Schatzki ring). Intermittent dysphagia to solids and liquids suggests motility disorder (achalasia, diffuse oesophageal spasm).
🚨
Urgent: New-onset progressive dysphagia with weight loss in any adult is oesophageal malignancy until proven otherwise. Refer for urgent upper GI endoscopy (OGD) within 2 weeks via the relevant state rapid-access clinic.

Associated questions: Is dysphagia for solids, liquids, or both? Any odynophagia (painful swallowing)? Any heartburn, regurgitation, or voice change? Prior caustic ingestion? History of radiotherapy?

Nausea and Vomiting

Assess the timing, content, and character of vomiting:

  • Projectile vomiting without nausea β€” consider raised intracranial pressure.
  • Faeculent (faeces-smelling) vomiting β€” suggests distal bowel obstruction or gastrocolic fistula.
  • Bilious (green) vomiting β€” small bowel obstruction below the ampulla of Vater; also gastric outlet obstruction (when no bile present).
  • Blood (haematemesis) β€” frank red blood (active bleeding) or "coffee-ground" (digested blood, slower bleed). Emergent assessment required.
  • Timing relative to meals β€” within 15 minutes (gastric cause); 1–3 hours (delayed gastric emptying); faeculent (distal obstruction).

Altered Bowel Habit

Document comprehensively using the Bristol Stool Chart (Types 1–7):

Pattern Description Key Differential
Constipation <3 bowel motions/week; hard stools (Bristol 1–2); straining; incomplete evacuation Functional (IBS-C), medications (opioids, calcium channel blockers), hypothyroidism, colonic malignancy, pelvic floor dysfunction
Diarrhoea >3 loose stools/day (Bristol 6–7); increased volume Acute: infection (viral, bacterial, parasitic). Chronic (>4 weeks): IBS-D, coeliac disease, IBD, microscopic colitis, bile acid malabsorption
Alternating pattern Constipation alternating with diarrhoea IBS-M, left-sided colonic malignancy (obstructive episodes)
Tenesmus Persistent urge to defaecate with no stool passed; rectal discomfort Rectal mass, IBD (proctitis), pelvic pathology

Rectal Bleeding

Characterise the bleeding carefully:

  • Bright red blood on paper or dripping into pan β€” anorectal source (haemorrhoids, anal fissure, rectal polyp).
  • Mixed with stool or altered colour β€” colonic source (colorectal cancer, IBD, diverticular disease).
  • Melaena (black, tarry, offensive stools) β€” upper GI source (peptic ulcer, oesophageal varices, gastric malignancy).
  • Occult blood (FOBT positive, no visible bleeding) β€” colorectal cancer screening detection; requires colonoscopy.
⚠️
National Bowel Cancer Screening Programme: Australians aged 50–74 receive a free immunochemical FOBT every 2 years. A positive result requires follow-up colonoscopy. Participation rates are lower in remote and Aboriginal and Torres Strait Islander populations.

Weight Loss

Unintentional weight loss is a cardinal red-flag symptom:

  • >5% body weight over 6 months β€” investigate for malignancy, malabsorption (coeliac disease, pancreatic exocrine insufficiency), IBD, or chronic infection.
  • Ask about appetite (anorexia), dietary changes, dysphagia limiting intake, vomiting, diarrhoea, and steatorrhoea.
  • Cachexia (severe muscle wasting) in the context of GI symptoms strongly suggests advanced malignancy or severe chronic disease.

Jaundice

Jaundice (yellow discolouration of skin and sclerae) becomes clinically apparent when serum bilirubin exceeds ~50 Β΅mol/L. History should include:

  • Duration and progression.
  • Pale stools (acholic) and dark urine (tea-coloured) β†’ obstructive (cholestatic) jaundice: gallstones, cholangiocarcinoma, pancreatic head malignancy, benign biliary stricture.
  • Normal-coloured stools with dark urine β†’ hepatocellular jaundice: hepatitis (viral, alcoholic, autoimmune, drug-induced), cirrhosis.
  • Associated RUQ pain, fever, rigors β†’ cholangitis (Charcot's triad: RUQ pain, jaundice, fever; Reynold's pentad adds hypotension and confusion).
  • Pruritus suggests cholestasis (intra- or extrahepatic).

Alcohol History

Alcohol history must be quantified and documented in every GI assessment:

  • Express intake in Australian standard drinks per day and per week (1 standard drink = 10 g ethanol = 285 mL full-strength beer, 100 mL wine, 30 mL spirits).
  • NHMRC guideline (2020): To reduce health risk from alcohol-related disease, healthy men and women should drink no more than 10 standard drinks per week and no more than 4 standard drinks on any one day.
  • Screening tools: CAGE questionnaire (Cut down, Annoyed, Guilty, Eye-opener β€” β‰₯2 positive is significant) and AUDIT-C (Alcohol Use Disorders Identification Test β€” Consumption).
  • Duration of heavy use is critical: cumulative lifetime alcohol exposure determines liver disease risk.
  • Assess for features of alcohol dependence: morning drinking, withdrawal symptoms (tremor, sweating, seizures, hallucinations), tolerance, loss of control.
ℹ️
Additional GI history domains to explore: family history (colorectal cancer, IBD, coeliac disease, hereditary polyposis syndromes), medications (NSAIDs, aspirin, anticoagulants, PPIs, iron, opioids, metformin, antibiotics), travel history (endemic parasites, travellers' diarrhoea), smoking status (peptic ulcer risk, Crohn's disease, GI malignancy), and previous surgery (adhesions, short bowel, bariatric surgery).

Abdominal Pain Patterns

Abdominal pain can be classified by mechanism: visceral (stretching of hollow viscus or capsule of solid organ β€” dull, poorly localised, midline), parietal/somatic (peritoneal inflammation β€” sharp, well-localised, worsened by movement), and referred (perceived at a site distant from the pathology β€” due to shared embryological dermatomes). The following patterns are essential for clinical examination in Australia:

Peptic Ulcer Disease (PUD)

Feature Gastric Ulcer (GU) Duodenal Ulcer (DU)
Site Epigastric, may radiate to back Epigastric, may radiate to back
Relation to food Worsened by food (within 30 min) Relieved by food ("hunger pain"); recurs 2–3 h post-meal
Timing Post-prandial Nocturnal (2–3 am); between meals
Weight Weight loss (anorexia) Weight gain (relief eating)
Associated NSAID use, H. pylori; weight loss β†’ exclude malignancy H. pylori (>90%), NSAIDs, smoking
Complication signs Haematemesis, melaena (perforation: sudden severe epigastric pain, rigid abdomen) Perforation (anterior DU), haemorrhage (posterior DU β€” gastroduodenal artery erosion)
🚨
Perforated peptic ulcer: Sudden onset severe epigastric pain ("like being stabbed"), board-like rigidity, absent bowel sounds, peritonitic signs. Air under diaphragm on erect CXR (or CT abdomen). This is a surgical emergency.

Biliary Pain (Biliary Colic & Cholecystitis)

  • Site: RUQ or epigastric, radiates to right shoulder tip or right subscapular region (via phrenic nerve C3–5).
  • Character: Intense, constant (not truly "colicky" despite the name), builds over 30–60 minutes then plateaus; lasts 1–6 hours.
  • Precipitants: Fatty meals, post-prandial (especially evening meal); may wake from sleep.
  • Associated: Nausea, vomiting, restlessness (cannot find comfortable position).
  • Murphy's sign: Arrest of inspiration during RUQ palpation over the gallbladder (positive in acute cholecystitis).
  • Charcot's triad (cholangitis): RUQ pain + jaundice + fever Β± rigors. Reynold's pentad adds hypotension and confusion (suppurative cholangitis).

Bowel Obstruction

Feature Small Bowel Obstruction (SBO) Large Bowel Obstruction (LBO)
Pain character Central/epigastric colicky (waxing and waning) Diffuse, colicky, may be constant if strangulation
Vomiting Early and prominent; initially gastric content, then bilious, eventually faeculent Late or absent (proximal colon decompressed via ileocaecal valve)
Distension Mild to moderate; may not be prominent proximal obstruction Marked, often visible
Bowel sounds High-pitched "tinkling" rushes coinciding with pain (early); absent (late/strangulation) Similar pattern but may be quiet
Flatus/ stool Absolute constipation (no flatus or stool) May pass flatus initially; absolute constipation later
Common causes Adhesions (most common), hernia (inguinal/incisional), Crohn's disease Colorectal cancer (most common), volvulus (sigmoid, caecal), diverticular stricture
🚨
Strangulation: Constant pain, peritonism, fever, tachycardia, metabolic acidosis, and leucocytosis in a patient with bowel obstruction suggest strangulation or ischaemia β€” this is a surgical emergency requiring immediate laparotomy.

Peritonitis

Peritoneal inflammation produces a characteristic clinical picture:

  • Generalised, severe pain β€” worsened by any movement; patient lies still, knees drawn up.
  • Rigid (guarding) abdomen β€” "board-like" rigidity (involuntary).
  • Rebound tenderness β€” pain on sudden release of palpation (release tenderness).
  • Percussion tenderness β€” pain on gentle percussion of the abdomen.
  • Absent or markedly reduced bowel sounds ("silent abdomen").
  • Systemic signs: Tachycardia, pyrexia, hypotension, oliguria.

Appendicitis

The classical progression of appendicitis (Alvarado score β€” clinical scoring system):

1
Central abdominal (visceral) pain
Periumbilical or epigastric, vague, dull, colicky β€” referred pain via visceral afferents (T10 dermatome).
2
Anorexia, nausea, vomiting
Nausea and vomiting typically follow the onset of pain (if vomiting precedes pain, consider alternative diagnosis).
3
Migration to RIF (somatic pain)
Pain localises to the RIF (McBurney's point β€” junction of lateral β…“ and medial β…” of line from umbilicus to ASIS) when the parietal peritoneum becomes inflamed. Sharp, localised, worse with movement/coughing.
4
Localised peritonism in RIF
Guarding, rebound tenderness, positive Rovsing's sign (pain in RIF on palpation of LIF). Low-grade fever (37.5–38.5Β°C). If abscess or perforation β†’ mass may be palpable.

Rovsing's sign: Pain in the RIF when pressure is applied to the LIF. Psoas sign: Pain on right hip extension (retrocaecal appendix irritating psoas). Obturator sign: Pain on internal rotation of flexed right hip (pelvic appendix irritating obturator internus).

⚠️
Atypical presentations: In children (<5 years), elderly, pregnant women, and patients on immunosuppression, the classical migration pattern may be absent. Appendicitis in pregnancy shifts the pain superiorly as the uterus enlarges. Maintain a low threshold for imaging (CT abdomen/pelvis or ultrasound).

Gastrointestinal Examination

The abdominal examination follows the IAPP sequence: Inspection β†’ Auscultation β†’ Percussion β†’ Palpation. Auscultation is performed before percussion and palpation because the act of palpation can alter bowel sounds. Always begin with general inspection of the patient.

General Signs

  • General appearance: Comfortable at rest vs. writhing in pain (renal/biliary colic) vs. lying still (peritonitis). Nutritional status β€” cachexia, signs of weight loss.
  • Face: Jaundice (examine sclerae in natural light), pallor (anaemia), angular stomatitis (iron/B12 deficiency), parotid enlargement (alcohol use), malar flush.
  • Mouth: Glossitis (smooth, red tongue β€” B12/iron deficiency), oral ulceration (IBD β€” Crohn's aphthous ulcers, BehΓ§et's), dental erosions (chronic vomiting, GORD).
  • Vital signs: Temperature, heart rate, blood pressure, respiratory rate, oxygen saturation. Tachycardia + hypotension suggests significant fluid depletion, sepsis, or haemorrhage.

Inspection

  • Expose the patient from xiphisternum to symphysis pubis (draping for dignity).
  • Contour: Flat, distended, scaphoid (very thin), asymmetrical.
  • Distension: Generalised (ascites, obesity, bowel obstruction, pregnancy) vs. localised (organomegaly, mass, bladder distension).
  • Scars: Previous surgery (midline laparotomy, right subcostal for cholecystectomy, appendicectomy scar in RIF, Pfannenstiel for Caesarean/gynaecological).
  • Stomas: Type (colostomy β€” mucosal; ileostomy β€” spout), content (faeculent, bile-stained), surrounding skin (excoriation suggests high-output stoma).
  • Visible masses, peristalsis, hernial orifices.
  • Caput medusae: Dilated periumbilical veins radiating outward β€” portal hypertension (patency confirmed by direction of flow: away from umbilicus).
  • Abdominal wall veins: Assess direction of flow β€” flow away from umbilicus (portal hypertension); flow upward from umbilicus (IVC obstruction); flow downward from umbilicus (SVC obstruction).

Auscultation

  • Use the diaphragm of the stethoscope. Listen in all four quadrants for at least 30 seconds in each.
  • Normal: Intermittent clicks and gurgles (5–35 sounds per minute).
  • Increased (hyperactive): Loud, high-pitched "tinkling" rushes β€” early mechanical bowel obstruction; also gastroenteritis, brisk diarrhoea.
  • Absent (silent): No bowel sounds after 3 minutes of listening β€” ileus (post-operative, metabolic, drugs), peritonitis, late bowel obstruction (strangulation).
  • Succussion splash: Rock the patient side to side while listening over the stomach β€” a splash >3 hours after eating suggests gastric outlet obstruction or gastroparesis.
  • Aortic bruit: Systolic bruit over the aorta β€” aortic stenosis or aneurysm. Renal artery bruits β€” lateral to midline, suggests renal artery stenosis.
  • Friction rubs: Liver (perihepatitis β€” Fitz-Hugh-Curtis syndrome) or spleen (splenic infarct, perisplenitis).

Percussion

  • Begin in the right iliac fossa and systematically percuss all nine regions.
  • Liver span: Percuss from the right iliac fossa upward. Normal dullness: 6–12 cm in the mid-clavicular line (varies with body habitus). Loss of liver dullness over the RUQ may indicate free air under the diaphragm (perforation).
  • Splenic percussion (Traube's space): Bounded by the left costal margin, anterior axillary line, and the horizontal line at the level of the lower border of the left tenth rib. Normally tympanitic. Dullness suggests splenomegaly (sensitivity increases when combined with percussion during inspiration).
  • Shifting dullness (for ascites): Percuss from the centre outward with the patient supine. Mark the boundary between tympany and dullness. Turn the patient on their side and re-percuss β€” if the dullness shifts, ascites is likely. A fluid thrill (transmitted impulse) suggests large-volume ascites (>1.5 L).
  • Bladder distension: Suprapubic dullness.

Palpation

Begin away from the site of pain, and ask the patient to breathe through the mouth to relax the abdominal wall muscles. Always use the flat of the hand initially (superficial palpation), then deeper pressure.

  • Superficial palpation: Assess for tenderness, guarding (voluntary β€” patient tenses on approach; involuntary β€” constant rigidity indicating peritonitis), and superficial masses.
  • Deep palpation: Systematically palpate all nine regions. Assess for deep masses and organomegaly.

Liver Palpation

  • Start in the right iliac fossa with the flat of the hand, fingers pointing toward the right costal margin.
  • Ask the patient to take a deep breath β€” feel the liver edge descend toward your fingers on inspiration.
  • Walk your fingers cephalad after each breath until you feel the liver edge (or reach the costal margin).
  • Describe: size (cm below costal margin or in cm span), surface (smooth vs. irregular/nodular), consistency (soft, firm, hard), tenderness, and edge (sharp vs. rounded).
Liver Character Consistency Surface Tenderness Suggested Cause
Tender, smooth hepatomegaly Soft to firm Smooth Tender Acute hepatitis, congestive cardiac failure (nutmeg liver), alcoholic hepatitis
Non-tender, smooth hepatomegaly Firm Smooth Non-tender Fatty liver (NAFLD, alcohol), early cirrhosis, infiltrative (amyloid, lymphoma)
Irregular, hard hepatomegaly Hard ("wooden") Irregular / nodular Usually non-tender Metastatic malignancy, hepatocellular carcinoma, advanced cirrhosis
Pulsatile liver Firm Smooth Variable Tricuspid regurgitation (systolic pulsation); hepatic artery pulsation (expansile β€” consider AAA)

Spleen Palpation

  • Begin in the right iliac fossa, moving diagonally toward the left costal margin.
  • Ask the patient to breathe deeply through the mouth. The spleen tip may be felt descending on inspiration.
  • If not palpable, roll the patient onto their right side (left side up) and re-palpate β€” this brings the spleen forward and closer to the palpating hand.
  • A normal spleen is not palpable. A palpable spleen is at least 1.5–2 times normal size.
⚠️
Never percuss or palpate aggressively over a suspected splenic mass β€” this risks splenic rupture in the setting of splenomegaly (e.g., glandular fever, malaria). Gentle palpation only.
Cause of Splenomegaly Size Examples
Mild (just palpable, 1–4 cm below costal margin) Up to 2Γ— normal Infectious mononucleosis, endocarditis, malaria, typhoid, IBD
Moderate (4–8 cm below costal margin) 2–3Γ— normal Haematological malignancy (lymphoma, CLL, myeloproliferative disorders), portal hypertension, haemolytic anaemia
Massive (>8 cm below costal margin, crosses midline) >3Γ— normal Chronic myeloid leukaemia, myelofibrosis, advanced portal hypertension, visceral leishmaniasis

Kidney Palpation (Bimanual Ballottement)

  • Place one hand posteriorly in the renal angle (loin) and the other anteriorly on the abdomen over the expected position of the kidney.
  • Press the posterior hand firmly forward and attempt to "bounce" the kidney between both hands (ballottement).
  • A palpable kidney is abnormally enlarged (polycystic kidney disease, hydronephrosis, renal cell carcinoma) or displaced (horseshoe kidney).
  • Percussion for renal tenderness: Gently strike the fist placed over the costovertebral angle β€” tenderness suggests pyelonephritis or perinephric abscess (renal angle tenderness).

Masses

When a mass is palpated, characterise using the mnemonic LLSSCC:

  • Location β€” which region/quadrant?
  • Loss of localisation (anterior vs. posterior β€” is it ballotable?)
  • Size β€” measure in centimetres or use anatomical landmarks (e.g., "3 cm below costal margin")
  • Surface β€” smooth, irregular, nodular
  • Consistency β€” soft (lipoma, cyst), firm (fibroid), hard (malignancy, faeces)
  • Characteristics β€” pulsatile (AAA, aortic aneurysm β€” assess for expansile vs. transmitted pulsation), mobile, tethered, tender
🚨
Expansile pulsatile mass in the central abdomen: Abdominal aortic aneurysm (AAA) until proven otherwise. Do not percuss or palpate aggressively. Arrange urgent CT aortogram. In Australia, the AAA screening programme recommends a one-off ultrasound for men aged 65–74 who have ever smoked.

Digital Rectal Examination (DRE)

DRE is an essential component of the GI examination when rectal bleeding, faecal incontinence, prostate disease, or pelvic pathology is suspected:

  • Explain the procedure and gain verbal consent. Position: left lateral (Sims' position) with knees drawn up.
  • Inspect the perianal region first: fissures (sentinel pile), haemorrhoids (prolapsed, thrombosed), fistulae, abscesses, warts, malignancy.
  • Lubricate the gloved index finger and gently insert, noting sphincter tone (reduced in cauda equina, pudendal neuropathy).
  • Palpate circumferentially: mucosal masses, faecal loading, prostate (smooth, enlarged = benign prostatic hyperplasia; hard, irregular, fixed = carcinoma).
  • Withdraw and inspect the glove for stool colour (melaena, clay-coloured) and blood.

Peripheral Signs of GI & Liver Disease

Systemic stigmata of GI and hepatobiliary disease are frequently visible on general and targeted examination. A systematic approach β€” beginning with the hands, arms, face, and trunk β€” is essential for clinical examination and provides valuable diagnostic clues.

Hands and Arms

Sign Description Associated Condition
Palmar erythema Red, warm palms β€” spares the thenar and hypothenar eminences; "liver palms" Chronic liver disease / cirrhosis (hyperdynamic circulation); also pregnancy, rheumatoid arthritis, thyrotoxicosis (normal variant in ~10%)
Leukonychia White discolouration of fingernails (partial or total) Hypoalbuminaemia (cirrhosis, nephrotic syndrome); zinc deficiency; also normal variant
Clubbing Loss of the nail bed angle (>180Β°); "floating" nail on palpation; increased nail fold fluctuance Coeliac disease (gluten-sensitive enteropathy), hepatocellular carcinoma, cirrhosis, IBD; also lung disease, cardiac disease
Terry's nails White proximal β…” of nail with distal pink band (2 mm) Cirrhosis, chronic hepatic congestion, hypoalbuminaemia
Muehrcke's lines Paired transverse white bands (do not move with nail growth β€” in the nail bed) Hypoalbuminaemia (albumin <20 g/L)
Dupuytren's contracture Thickening and shortening of palmar fascia, most commonly the ring and little fingers Alcoholic liver disease (association); also diabetes, manual labour, epilepsy (phenytoin)
Asterixis (flapping tremor) "Liver flap" β€” with arms outstretched, wrists dorsiflexed, irregular downward flapping of the hands Hepatic encephalopathy; also uraemia, COβ‚‚ retention, drug effects
Fine tremor Postural/kinetic tremor of outstretched hands Alcohol withdrawal; also thyrotoxicosis, medications

Face

  • Jaundice: Yellow discolouration of sclerae (best examined in natural light by asking the patient to look upward), skin, and sublingual tissue. Bilirubin >50 Β΅mol/L to become clinically apparent.
  • Pallor: Anaemia β€” conjunctival pallor (pull down lower eyelid), palmar creases (should be pink, not white). Iron deficiency is common in coeliac disease, IBD, and GI malignancy.
  • Angular stomatitis / cheilosis: Cracking at the corners of the mouth β€” iron deficiency, B12 deficiency, riboflavin deficiency, ill-fitting dentures.
  • Glossitis: Smooth, red, painful tongue β€” iron deficiency (atrophic papillae), B12 deficiency (beefy red tongue).
  • Parotid gland enlargement: Bilateral β€” chronic alcohol use; also SjΓΆgren's syndrome, HIV, bulimia.
  • Kayser-Fleischer rings: Golden-brown copper deposits at the periphery of the cornea (Descemet's membrane) β€” Wilson's disease (a cause of liver disease in young patients).

Spider Naevi

Spider naevi (spider angiomas) are vascular lesions consisting of a central arteriole with radiating small vessels. Key features:

  • Appearance: Central red punctum with radiating "legs" (capillaries); blanch on pressure and refill from the centre outward.
  • Distribution: Upper body β€” face, neck, upper chest, upper arms, and hands (above the level of the nipple β€” in the SVC drainage territory). Look in the dermatomes of C3, C4, C5.
  • Clinical significance: β‰₯5 spider naevi are highly specific for chronic liver disease / cirrhosis (hyperoestrogenism due to impaired hepatic oestrogen metabolism). Isolated spider naevi may occur in pregnancy and are normal in children.
  • Pathophysiology: Increased circulating oestrogen (normally metabolised by the liver) causes vasodilatation mediated by nitric oxide.

Palmar Erythema

Bilateral, symmetrical redness of the palms, most prominent on the thenar and hypothenar eminences, with sparing of the central palm (though in severe cases the entire palm may be involved). A common finding in chronic liver disease (occurring in up to 23% of patients with cirrhosis). Also seen in pregnancy, rheumatoid arthritis, and as a normal variant in approximately 10% of the population. Caused by hyperdynamic circulation and peripheral vasodilatation.

Gynaecomastia

Enlargement of male breast tissue due to oestrogen-androgen imbalance. Characteristically tender, subareolar, and palpable as a firm disc of tissue beneath the nipple. Distinguished from lipomastia (pseudogynaecomastia β€” diffuse fatty enlargement without a discrete disc) by careful palpation.

  • GI causes: Cirrhosis (alcoholic and non-alcoholic β€” impaired oestrogen metabolism), alcoholic liver disease (direct testicular atrophy), spironolactone therapy.
  • Other causes: Puberty (physiological), testicular tumours, Klinefelter syndrome, drug-induced (cimetidine, oestrogens, anabolic steroids, marijuana, phenytoin), hyperthyroidism.

Ascites

Ascites is pathological accumulation of fluid in the peritoneal cavity. Clinical examination techniques:

1
Inspection
Generalised distension; flank bulging; umbilical eversion (with large volume). Check for caput medusae (periumbilical venous distension).
2
Percussion β€” Shifting dullness
Percuss from the umbilicus laterally. Mark the tympany–dullness boundary. Roll the patient onto one side and re-percuss. If the dullness shifts, ascites is confirmed (sensitivity ~83%, specificity ~56% for >1.5 L).
3
Fluid thrill
Place the edge of the patient's hand (or an assistant's hand) firmly along the midline of the abdomen. Flick one flank while feeling the other. A transmitted thrill indicates large-volume ascites (>1.5 L).
4
Puddle sign (small-volume ascites)
Patient on all fours; percuss from flanks toward the midline. Dullness in the dependent area suggests small-volume ascites (120–500 mL). Rarely used in practice.

Causes of ascites (use serum-ascites albumin gradient [SAAG] to differentiate):

SAAG β‰₯ 11 g/L (Portal hypertension) SAAG < 11 g/L (Non-portal hypertensive)
Cirrhosis (most common in Australia) Peritoneal carcinomatosis
Alcoholic hepatitis Tuberculous peritonitis
Cardiac failure (right heart) Nephrotic syndrome
Budd-Chiari syndrome Pancreatitis (pancreatic ascites)
Myxoedema Serositis (SLE)
ℹ️
Spontaneous bacterial peritonitis (SBP): Consider in any cirrhotic patient with ascites who develops fever, abdominal pain, worsening encephalopathy, or renal impairment. Diagnostic paracentesis: ascitic fluid polymorphonuclear (PMN) count β‰₯250 cells/mmΒ³. First-line treatment: IV ceftriaxone 2 g daily (eTG Antibiotic). SBP prophylaxis: norfloxacin 400 mg PO daily (or ciprofloxacin) in patients with prior SBP or GI bleeding.

Other Peripheral Signs

  • Testicular atrophy: Bilateral small, soft testes β€” chronic alcohol use (direct toxic effect + oestrogen excess), liver cirrhosis, Klinefelter syndrome.
  • Axillary hair loss: Reduced axillary hair in women β€” may occur with hypoandrogenism secondary to cirrhosis.
  • Loss of body hair: Generalised hair thinning β€” malnutrition, coeliac disease, chronic illness.
  • Peripheral oedema: Bilateral pitting ankle oedema β€” hypoalbuminaemia (cirrhosis, nephrotic syndrome, malnutrition), right heart failure, DVT. Unilateral β€” DVT, venous insufficiency.
  • Scratch marks (excoriations): Pruritus β€” cholestatic liver disease (primary biliary cholangitis, primary sclerosing cholangitis, drug-induced cholestasis, obstructive jaundice).
  • Tattoo or injection marks: May indicate intravenous drug use β€” hepatitis B/C risk.

Special Populations

🀰

Pregnancy

Nausea and vomiting
Hyperemesis gravidarum: persistent vomiting >5% pre-pregnancy weight, ketonuria, electrolyte derangement. Exclude other causes (UTI, thyroid disease, molar pregnancy). Investigations: FBC, UEC, LFTs, TFTs, serum Ξ²-hCG. Management: ondansetron (Category B1), pyridoxine + doxylamine, IV fluids, thiamine if prolonged.
Abdominal examination
The gravid uterus displaces intra-abdominal organs. The appendix migrates superiorly β€” RIF pain may actually be RUQ pain in the third trimester. Murphy's sign may be absent due to the uterus interposing. Always consider pregnancy in any woman of childbearing age presenting with abdominal pain β€” perform a urine pregnancy test (Ξ²-hCG) before imaging.
GORD in pregnancy
Very common (up to 80%). Progesterone relaxes the lower oesophageal sphincter; the uterus elevates intra-abdominal pressure. Lifestyle measures first; antacids (calcium carbonate), Gaviscon, ranitidine (Category B1 β€” now limited availability), omeprazole (Category B3 β€” use if benefits outweigh risks).
πŸ‘Ά

Paediatrics

Abdominal pain
Common presentations vary by age: infants (colic, intussusception, volvulus, Hirschsprung's), toddlers (intussusception, appendicitis), school-age (appendicitis, constipation, functional abdominal pain), adolescents (appendicitis, IBD, IBS, ectopic pregnancy in females). Red flags: pain waking from sleep, weight loss, bloody stools, peritonitis.
Intussusception
Peak age 6 months – 2 years. Triad: episodic colicky abdominal pain, vomiting, redcurrant jelly stools (late sign). Palpable sausage-shaped mass in the RUQ (descending colon). Diagnosis: ultrasound (target sign) or air enema (both diagnostic and therapeutic). Refer urgently to paediatric surgery.
GI examination in children
Examination technique must be adapted β€” observe the child on the parent's lap first; use distraction and warmth; palpate gently with the flat of the hand; ask the child to point; use a toy or stethoscope playfully. Auscultate while the child is calm. Never force a crying child to allow deep palpation.
πŸ‘΄

Elderly

Atypical presentations
Elderly patients with appendicitis, cholecystitis, or bowel obstruction may present without fever, without significant pain, or with nonspecific confusion and functional decline. Mesenteric ischaemia (acute β€” surgical emergency; chronic β€” "intestinal angina" with post-prandial pain and food aversion) should be considered in any elderly patient with abdominal pain out of proportion to examination findings.
Polypharmacy
Medications commonly contribute to GI symptoms in the elderly β€” NSAIDs (GI bleeding, ulcers), opioids (constipation, ileus), anticholinergics (constipation, urinary retention), antibiotics (C. difficile infection). Always review the medication chart.
Sarcopenia and frailty
Reduced muscle mass may mask peritoneal signs (guarding). Cachexia may indicate underlying malignancy. Osteoporotic vertebral fractures may cause referred abdominal pain. Consider colorectal cancer screening participation and endoscopy fitness (ASA grading, anticoagulant management).
🫘

Renal Impairment

Uraemia
Uraemic patients may develop nausea, vomiting, anorexia, hiccoughs, and GI bleeding (platelet dysfunction). Asterixis is common in end-stage renal failure. Dialysis patients are at increased risk of GI complications including ischaemic colitis, diverticular disease, and pancreatitis.
Peritoneal dialysis
Patients on peritoneal dialysis presenting with abdominal pain require exclusion of peritonitis (cloudy PD fluid, elevated cell count >100 WBC/mmΒ³, Gram stain, culture). Treat empirically with intraperitoneal antibiotics per ISPD guidelines (e.g., vancomycin + ceftazidime or cefazolin + gentamicin).
🫁

Hepatic Impairment

Child-Pugh scoring
Assess severity of liver disease using the Child-Pugh score (bilirubin, albumin, INR, ascites, encephalopathy). Class A (5–6, well-compensated), Class B (7–9, significant functional compromise), Class C (10–15, decompensated). This guides prognosis and medication safety β€” many drugs require dose adjustment or are contraindicated (e.g., NSAIDs, paracetamol in excess, certain antibiotics).
Hepatorenal syndrome
Type 1 (rapid β€” doubling of creatinine to >226 Β΅mol/L within 2 weeks) and Type 2 (slow β€” creatinine >133 Β΅mol/L). Occurs in advanced cirrhosis with ascites. Diagnosis requires exclusion of other causes (shock, nephrotoxins, obstruction). Treatment: terlipressin + albumin (if available) or noradrenaline; definitive treatment is liver transplantation.
πŸ›‘οΈ

Immunocompromised

Broad differential
Immunocompromised patients (HIV/AIDS, transplant recipients, chemotherapy, biologics, corticosteroids) may develop opportunistic GI infections (CMV colitis, oesophageal candidiasis, cryptosporidiosis, Mycobacterium avium complex) or present with atypical/severe versions of common infections. C. difficile colitis may be fulminant. Malignancy (GI lymphoma, Kaposi's sarcoma) must be considered. Fever, pain, and diarrhoea should be investigated urgently with stool cultures, endoscopy, and CT as indicated.
Neutropenic enterocolitis (typhlitis)
Life-threatening condition in neutropenic patients (neutrophils <0.5 Γ— 10⁹/L). Presents with fever, abdominal pain (especially RLQ), and diarrhoea. CT shows caecal wall thickening. Management: broad-spectrum antibiotics (piperacillin-tazobactam or meropenem per eTG), bowel rest, G-CSF. Surgical consult early.
Aboriginal and Torres Strait Islander Health
Disease burden
Aboriginal and Torres Strait Islander Australians experience significantly higher rates of gastrointestinal disease compared to non-Indigenous Australians. Hepatocellular carcinoma incidence is 2–4 times higher, driven by greater prevalence of hepatitis B (chronic carriage rates 2–5Γ— higher in some remote communities), hepatitis C, and harmful alcohol use. Gastric cancer and gallstone-related disease are also more prevalent. H. pylori infection rates are markedly higher, particularly in remote communities, contributing to higher rates of peptic ulcer disease and gastric cancer.
Culturally safe examination
Build rapport and trust before proceeding with physical examination. Ask permission to examine the abdomen. Explain each step clearly. Some Aboriginal and Torres Strait Islander patients may prefer a health practitioner of the same gender. In some communities, certain body areas may be considered sensitive (e.g., the abdomen). Same-sex examination should be offered where possible, and a chaperone or health worker should be available. Always use respectful, non-judgemental language, particularly when enquiring about alcohol use.
Hepatitis B screening
The Australian National Hepatitis B Strategy prioritises Aboriginal and Torres Strait Islander peoples for screening. All Aboriginal and Torres Strait Islander people should be offered hepatitis B serology (HBsAg, anti-HBs, anti-HBc) at least once in their lifetime if not previously tested. Vaccination should be offered to all non-immune individuals. In the Northern Territory, the hepatitis B vaccination programme has shown significant success in reducing carriage rates in younger cohorts.
Alcohol and substance use
Harmful alcohol use contributes disproportionately to liver disease, pancreatitis, and GI malignancy in Aboriginal and Torres Strait Islander communities. Approaches must be non-stigmatising and trauma-informed. The AUDIT-C tool is validated for use in Aboriginal and Torres Strait Islander health settings. Dry communities (alcohol management plans) exist in some remote areas. Fetal alcohol spectrum disorder (FASD) screening is also relevant in paediatric GI assessment.
Bowel cancer screening
Participation in the National Bowel Cancer Screening Programme (NBCSP) is significantly lower among Aboriginal and Torres Strait Islander peoples (~26% vs. ~42% in non-Indigenous Australians). Barriers include health literacy, cultural attitudes to faecal testing, geographic remoteness, and access to follow-up colonoscopy. Community-based health promotion programmes led by Aboriginal Community Controlled Health Organisations (ACCHOs) can improve uptake. Endoscopy services are limited in remote areas, requiring significant travel.
Remote and rural access
Many Aboriginal and Torres Strait Islander people live in remote and very remote areas where access to gastroenterology specialists, endoscopy, and advanced imaging is limited. Royal Flying Doctor Service (RFDS) and visiting specialist clinics (e.g., Endoscopy bus services) are essential models of care. Telehealth consultations for GI assessment and follow-up are increasingly used. Diagnostic delays due to geographic barriers contribute to later-stage presentation of GI cancers.
Social determinants
Overcrowded housing, food insecurity (limited access to fresh fruit and vegetables in remote communities β€” "food deserts"), poor sanitation, and limited clean water supply contribute to higher rates of H. pylori infection, gastroenteritis, and chronic GI disease. Addressing social determinants is essential for sustainable improvements in GI health outcomes.

πŸ“š References

  1. 1. Talley NJ, O'Connor S. Clinical Examination: A Systematic Guide to Physical Diagnosis. 8th ed. Sydney: Elsevier; 2018.
  2. 2. Australian Institute of Health and Welfare (AIHW). Cancer in Australia 2021. AIHW; 2021. Available from: https://www.aihw.gov.au/reports/cancer/cancer-in-australia-2021.
  3. 3. National Health and Medical Research Council (NHMRC). Australian Guidelines to Reduce Health Risks from Drinking Alcohol. Canberra: NHMRC; 2020.
  4. 4. Royal Australian College of General Practitioners (RACGP). Guidelines for Preventive Activities in General Practice (Red Book). 9th ed. Melbourne: RACGP; 2016 (updated 2018).
  5. 5. Australian Government Department of Health. National Bowel Cancer Screening Programme: Programme Handbook. Canberra: Department of Health; 2022.
  6. 6. Gastroenterological Society of Australia (GESA). Clinical Guidelines for the Management of Chronic Hepatitis B. Sydney: GESA; 2022.
  7. 7. Runyon BA; AASLD Practice Guidelines Committee. Management of adult patients with ascites due to cirrhosis: an update. Hepatology. 2009;49(6):2087–2107.
  8. 8. Aboriginal and Torres Strait Islander Health Performance Framework. AIHW Analysis of Key Indicators. Canberra: AIHW; 2023.
  9. 9. Alvarado A. A practical score for the early diagnosis of acute appendicitis. Ann Emerg Med. 1986;15(5):557–564.
  10. 10. College of Intensive Care Medicine of Australia and New Zealand (CICM). Abdominal Examination β€” Clinical Skills. Melbourne: CICM; 2020.
  11. 11. Australasian Society for Infectious Diseases (ASID). Guidelines for the Management of Spontaneous Bacterial Peritonitis. Sydney: ASID; 2019.
  12. 12. Australian Commission on Safety and Quality in Health Care (ACSQHC). National Safety and Quality Health Service Standards. 2nd ed. Sydney: ACSQHC; 2021.
  13. 13. Heckerling PS. Palpation of splenomegaly. JAMA. 1991;265(21):2862–2863.
  14. 14. Clinical Excellence Commission, NSW Health. Clinical Examination of the Abdomen β€” Clinical Practice Guideline. Sydney: NSW Health; 2019.
for PBS-listed medicines at participating pharmacies.
Cultural safety
Engagement with Aboriginal Community Controlled Health Organisations (ACCHOs) is essential. Cultural safety training for non-Indigenous clinicians, use of Aboriginal Health Workers and Liaison Officers, and incorporation of traditional healing practices alongside Western medicine improve treatment adherence and outcomes. Avoidance of eye contact, respect for gender-sensitive examination practices, and understanding of sorry business protocols are critical elements of culturally safe care.
Medication adherence
Complex DMARD regimens with frequent monitoring requirements present adherence challenges. Long-acting depot injections (e.g., methotrexate SC) may improve adherence compared to oral regimens. Community pharmacy partnerships through the Indigenous Pharmacy Programmes improve medication management.
Specific conditions
Rheumatic heart disease (RHD) requires secondary prophylaxis with benzathine penicillin G (BPG) 1.2 MU IM every 3–4 weeks for a minimum of 10 years or until age 21 (whichever is longer). RHD registers (e.g., NT RHD Register) facilitate recall and follow-up. The Australian RHD Endgame Strategy targets elimination by 2031.
Referral pathways
Referral through ACCHOs and Aboriginal Hospital Liaison Officers (AHLOs) improves engagement. The Specialist Outreach Assistance Programme provides funded specialist visits to remote communities. NT, WA, and QLD have specific rheumatology outreach programmes targeting Indigenous communities.

πŸ“š References

  1. 1. Australian Institute of Health and Welfare (AIHW). Autoimmune disease in Australia. Cat. no. PHE 312. Canberra: AIHW; 2023.
  2. 2. Fraenkel L, Bathon JM, England BR, et al. 2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care Res. 2021;73(7):924–939.
  3. 3. Fanouriakis A, Kostopoulou M, Alber K, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78(6):736–745.
  4. 4. Chung SA, Langford CA, Maz M, et al. 2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Care Res. 2021;73(11):1583–1599.
  5. 5. Smolen JS, LandewΓ© RBM, Bijlsma JWJ, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis. 2023;82(1):3–18.
  6. 6. Australian Technical Advisory Group on Immunisation (ATAGI). Australian Immunisation Handbook. Australian Government Department of Health; 2024. Available from: immunisationhandbook.health.gov.au.
  7. 7. Rheumatic Heart Disease Australia (RHDAustralia). The 2020 Australian guideline for prevention, diagnosis, and management of acute rheumatic fever and rheumatic heart disease. 3rd ed. Darwin: Menzies School of Health Research; 2020.
  8. 8. Pharmaceutical Benefits Scheme (PBS). PBS Schedule. Australian Government Department of Health. Available from: pbs.gov.au. Accessed 2024.
  9. 9. Agarwal S, Cunnington J, Nossent J. Autoimmune disease in Indigenous Australians: a systematic review. Int J Rheum Dis. 2021;24(12):1487–1498.
  10. 10. Pisetsky DS. Antinuclear antibody testing β€” misunderstood or misused? Clin Immunol. 2023;255:109717.
  11. 11. Bertsias GK, Tektonidou M, Amoura Z, et al. Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis. 2012;71(11):1771–1782.
  12. 12. Ledingham J, Deighton C; British Society for Rheumatology Standards, Audit and Guidelines Working Group. Update on the British Society for Rheumatology guidelines for prescribing TNFΞ± blockers in adults with rheumatoid arthritis. Rheumatology. 2005;44(2):155–158.
  13. 13. National Health and Medical Research Council (NHMRC). National statement on ethical conduct in human research. Canberra: NHMRC; 2023 (updated).
for PBS-listed medicines at participating pharmacies.
Cultural safety
Engagement with Aboriginal Community Controlled Health Organisations (ACCHOs) is essential. Cultural safety training for non-Indigenous clinicians, use of Aboriginal Health Workers and Liaison Officers, and incorporation of traditional healing practices alongside Western medicine improve treatment adherence and outcomes. Avoidance of eye contact, respect for gender-sensitive examination practices, and understanding of sorry business protocols are critical elements of culturally safe care.
Medication adherence
Complex DMARD regimens with frequent monitoring requirements present adherence challenges. Long-acting depot injections (e.g., methotrexate SC) may improve adherence compared to oral regimens. Community pharmacy partnerships through the Indigenous Pharmacy Programmes improve medication management.
Specific conditions
Rheumatic heart disease (RHD) requires secondary prophylaxis with benzathine penicillin G (BPG) 1.2 MU IM every 3–4 weeks for a minimum of 10 years or until age 21 (whichever is longer). RHD registers (e.g., NT RHD Register) facilitate recall and follow-up. The Australian RHD Endgame Strategy targets elimination by 2031.
Referral pathways
Referral through ACCHOs and Aboriginal Hospital Liaison Officers (AHLOs) improves engagement. The Specialist Outreach Assistance Programme provides funded specialist visits to remote communities. NT, WA, and QLD have specific rheumatology outreach programmes targeting Indigenous communities.

πŸ“š References

  1. 1. Australian Institute of Health and Welfare (AIHW). Autoimmune disease in Australia. Cat. no. PHE 312. Canberra: AIHW; 2023.
  2. 2. Fraenkel L, Bathon JM, England BR, et al. 2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care Res. 2021;73(7):924–939.
  3. 3. Fanouriakis A, Kostopoulou M, Alber K, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78(6):736–745.
  4. 4. Chung SA, Langford CA, Maz M, et al. 2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Care Res. 2021;73(11):1583–1599.
  5. 5. Smolen JS, LandewΓ© RBM, Bijlsma JWJ, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis. 2023;82(1):3–18.
  6. 6. Australian Technical Advisory Group on Immunisation (ATAGI). Australian Immunisation Handbook. Australian Government Department of Health; 2024. Available from: immunisationhandbook.health.gov.au.
  7. 7. Rheumatic Heart Disease Australia (RHDAustralia). The 2020 Australian guideline for prevention, diagnosis, and management of acute rheumatic fever and rheumatic heart disease. 3rd ed. Darwin: Menzies School of Health Research; 2020.
  8. 8. Pharmaceutical Benefits Scheme (PBS). PBS Schedule. Australian Government Department of Health. Available from: pbs.gov.au. Accessed 2024.
  9. 9. Agarwal S, Cunnington J, Nossent J. Autoimmune disease in Indigenous Australians: a systematic review. Int J Rheum Dis. 2021;24(12):1487–1498.
  10. 10. Pisetsky DS. Antinuclear antibody testing β€” misunderstood or misused? Clin Immunol. 2023;255:109717.
  11. 11. Bertsias GK, Tektonidou M, Amoura Z, et al. Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis. 2012;71(11):1771–1782.
  12. 12. Ledingham J, Deighton C; British Society for Rheumatology Standards, Audit and Guidelines Working Group. Update on the British Society for Rheumatology guidelines for prescribing TNFΞ± blockers in adults with rheumatoid arthritis. Rheumatology. 2005;44(2):155–158.
  13. 13. National Health and Medical Research Council (NHMRC). National statement on ethical conduct in human research. Canberra: NHMRC; 2023 (updated).